# Observational Crohn Disease studies recruiting: 144 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 144 trials that are observational for Crohn Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Crohn Disease studies: 144 rows for $7.20, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 6 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/crohn-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 144
- Recruiting or not yet: 144
- Read on: November 19, 2026

## Trials

The 25 newest of 144, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 23, 2026 | NCT07892651 | MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) | Sponsor not shown (see the record) | Observational | Not yet recruiting | Antiphospholipid (aPL)-Positive, Rheumatic Arthritis, Celiac Disease, Focal Segmental Glomerulosclerosis (FSGS)... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892651) |
| October 22, 2026 | NCT07888023 | Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative (UC), Malnutrition | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888023) |
| October 16, 2026 | NCT07877649 | Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease | First Affiliated Hospital, Sun Yat-Sen University | Observational | Not yet recruiting | Inflammatory Bowel Diseases (IBD), Crohn Disease, Colitis, Ulcerative | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877649) |
| October 13, 2026 | NCT07871383 | Effect of Intestinal Carriage of \*Pilosibacter Rotomagensis\* on Intestinal Inflammatory Activity | University Hospital, Rouen | Observational | Not yet recruiting | Crohn's Diseases | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871383) |
| October 2, 2026 | NCT07855055 | Early Changes in Inflammatory Indices and Healing in IBD | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Disease, Ulcerative Colitis, Crohn Disease | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855055) |
| October 1, 2026 | NCT07851207 | A Study to Assess Guselkumab in Participants With Moderate-to-Severe Inflammatory Bowel Disease in Real Life Italian Setting | Janssen-Cilag Ltd. | Observational | Not yet recruiting | Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851207) |
| September 30, 2026 | NCT07848737 | A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis | Janssen-Cilag, S.A. | Observational | Not yet recruiting | Colitis, Ulcerative, Crohn Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848737) |
| September 17, 2026 | NCT07824791 | Prediction of Postoperative Recurrence in Crohn's Disease | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Recruiting | Crohn Disease (CD), Postoperative Recurrence and Metastasis | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824791) |
| September 16, 2026 | NCT07821645 | Modulen IBD for Induction and Maintenance of Remission in Pediatric Crohn's Disease | Assiut University | Observational | Not yet recruiting | Crohn Disease, Inflammatory Bowel Diseases, Pediatric Crohns Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821645) |
| September 14, 2026 | NCT07818473 | Conventional vs Biologic Therapy in Pediatric IBD | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818473) |
| September 10, 2026 | NCT07814274 | Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development | University of British Columbia | Observational | Not yet recruiting | Inflammatory Bowel Disease (IBD) | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814274) |
| September 10, 2026 | NCT07812675 | Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion... | Centre Hospitalier Universitaire de Nīmes | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn's Disease, Skin Diseases, Dermatitis | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812675) |
| September 2, 2026 | NCT07799506 | Accurately Profiling the Changes and Functions of Key Microflora in the Whole Intestinal Microenvironment Based on the Visual Sampling... | Changhai Hospital | Observational | Not yet recruiting | Crohn's Disease (CD), Ulcerative Colitis (UC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799506) |
| August 31, 2026 | NCT07795476 | Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient... | PharmaNest, Inc | Observational | Not yet recruiting | Crohn Disease, Fibrostenotic Crohn's Disease, CD - Crohn's Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795476) |
| August 28, 2026 | NCT07791862 | Familial Inflammatory Bowel Disease Early Risk | Seattle Children's Hospital | Observational | Recruiting | Inflammatory Bowel Disease (Crohn&#39;s Disease and Ulcerative Colitis), Crohn Disease (CD), Ulcerative Colitis (UC) | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07791862) |
| August 26, 2026 | NCT07788131 | Inflammatory Biomarkers and Disease Activity in Inflammatory Bowel Disease | Assiut University | Observational | Not yet recruiting | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis (UC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07788131) |
| August 24, 2026 | NCT07781215 | E-nose in Evaluating Colitis Activity | Tampere University Hospital | Observational | Not yet recruiting | IBD (Inflammatory Bowel Disease) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781215) |
| August 18, 2026 | NCT07770425 | Lesion Size Measurement During Gastrointestinal Endoscopies | Centre hospitalier de l'Université de Montréal (CHUM) | Observational | Recruiting | Polyp of Colon, Crohn Disease | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770425) |
| August 5, 2026 | NCT07746765 | A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting | Janssen Sciences Ireland UC | Observational | Not yet recruiting | Crohn Disease, Colitis, Ulcerative | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746765) |
| July 31, 2026 | NCT07740499 | TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease | IRCCS San Raffaele | Observational | Not yet recruiting | Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740499) |
| July 22, 2026 | NCT07719426 | Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a... | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Observational | Recruiting | Crohn Disease (CD), Colitis Ulcerative | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07719426) |
| July 17, 2026 | NCT07710287 | Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD | IRCCS Policlinico S. Donato | Observational | Recruiting | Ulcerative Colitis (UC), Crohn Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710287) |
| July 10, 2026 | NCT07694674 | Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease | Shanghai 10th People's Hospital | Observational | Recruiting | Inflamatory Bowel Disease, Crohn Disease (CD) | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694674) |
| July 7, 2026 | NCT07686406 | IBD Biomarker Discovery and Validation Platform | Sixth Affiliated Hospital, Sun Yat-sen University | Observational | Recruiting | Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD) | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686406) |
| July 2, 2026 | NCT07682038 | Retrospective Observational Multicenter Study on the Treatment Patterns, Extra-Intestinal Manifestations, Resource Utilisation, and... | LOGEX | Observational | Not yet recruiting | Crohn Disease, Inflammatory Bowel Disease (IBD), Colitis Ulcerative | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682038) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 6 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 4 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 3 |
| University of British Columbia | 3 |
| Massachusetts General Hospital | 3 |
| IRCCS San Raffaele | 3 |
| IRCCS Policlinico S. Donato | 3 |
| University Hospital, Grenoble | 2 |
| University College, London | 2 |
| Seattle Children's Hospital | 2 |
| [Janssen-Cilag Ltd.](https://specstream.ai/data/clinical-trials/company/janssen-cilag-ltd) | 2 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 2 |
| Imelda GI Clinical Research Center | 2 |
| Nantes University Hospital | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| University of North Carolina, Chapel Hill | 2 |
| Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2 |
| Shanghai 10th People's Hospital | 2 |
| McMaster University | 2 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Hamilton Health Sciences Corporation | 1 |
| Tzaneio General Hospital | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Seoul National University Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| France | 19 |
| China | 16 |
| Italy | 11 |
| Canada | 10 |
| United Kingdom | 9 |
| South Korea | 6 |
| Israel | 5 |
| Germany | 5 |
| Netherlands | 4 |
| Spain | 4 |
| Poland | 3 |
| Belgium | 3 |
| Taiwan | 2 |
| Denmark | 2 |
| Turkey (Türkiye) | 2 |
| Hong Kong | 2 |
| Greece | 1 |
| Switzerland | 1 |
| Jordan | 1 |
| Norway | 1 |
| Austria | 1 |
| Australia | 1 |
| Saudi Arabia | 1 |
| Chile | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Bathroom remodelers in the United States](https://specstream.ai/data/businesses/bathroom-remodelers/united-states)
- [Lebanese restaurants in the United States](https://specstream.ai/data/businesses/lebanese-restaurants/united-states)
- [Woodworking supply stores in the United States](https://specstream.ai/data/businesses/woodworking-supply-stores/united-states)
- [Grout companies in the United States](https://specstream.ai/data/businesses/grout-companies/united-states)
- [Suppliers and distributors in the United States](https://specstream.ai/data/businesses/suppliers-and-distributors/united-states)
- [Education services in the United States](https://specstream.ai/data/businesses/education-services/united-states)
